IMAGINE TAKING YOUR STEM CELL THERAPY PRACTICE TO THE NEXT LEVEL ALL BY DEVOTING A FEW MINUTES A DAY TO CREATING A GAME CHANGING BOOK FOR YOUR PRACTICE, AND YOUR PATIENTS. THE SAD TRUTH IS THAT YOU AS A DOCTOR OF CHIROPRACTIC HIGHLY EDUCATED BUT AN UNDERVALUED MEMBER OF THE MEDICAL COMMUNITY. YOU ARE SELDOM SEEN AS AN AUTHORITY EVEN THOUGH YOU’VE GRADUATED FROM A CREDENTIALED CHIROPRACTIC SCHOOL ANDPASSED ALL OF YOUR BOARDS. IT’S STILL NOT ENOUGH. YOU KNOW WHAT YOU ARE DOING WHEN IT COMES TO MAKING A DIFFERENCE, AND YET THERE IS PUSHBACK, RESISTANCE, AND BOTTOM LINE SKEPTICISM. SO, HOW DO YOU EDUCATE THE PUBLIC, GAIN THE CREDIBILITY AND AUTHORITY YOU DESERVE WHILE AT THE SAME TIME DRAMATICALLY ELEVATING YOUR STATUS WITH YOUR PATIENTS?IN TURBOCHARGE YOUR STEM CELL PRACTICE WITH THE POWER OF AUTHORITY MARKETING, DR. STEVEN RAPOSO, A CHIROPRACTOR, AND AUTHOR OF 5 BOOKS, OUTLINES A POWERFUL METHOD TO DO JUST THAT: BECOME A TRUSTED AUTHORITY IN STEM CELLS BY BECOMING A PUBLISHED AUTHOR ON THE SUBJECT. BECOMING A PUBLISHED AUTHOR CAN HAVE INVALUABLE EFFECTS ON YOUR PRACTICETHESE INCLUDE:BECOMING AN AUTOMATIC AUTHORITYGENERATING LEADS FOR YOUR STEM CELL PRACTICEDISPELLING MYTHS SURROUNDING CHIROPRACTICBECOMING A LOCAL CELEBRITY AND THEREBY GAINING THE TRUST AND RESPECT OD YOURCOMMUNITY.BUILDING A LOYAL FOLLOWNG OF FANS AND PATIENTS.TURBOCHARGE YOUR STEM CELL PRACTICE WITH THE POWER OF AUTHORITY MARKETING SHARES WITH YOU WHY WRITING A BOOK ON CHIROPRACTIC IS A MUST FOR YOUR PRACTICE AND YOURCREDIBILITY. IN THIS BOOK HE ALSO SHARES WITH YOU HOW TO OPTIMIZE YOURSTATUS AS AN AUTHOR BY REVEALING POWERFUL STRATEGIES THAT CAN TAKE YOURPRACTICE TO THE NEXT LEVEL WITH THE POWER OF AUTHORITY MARKETING. THISSYSTEM HAS BEEN OPTIMIZED AND STREAMLINED SO THAT EVEN CHIROPRACTORSWITH THE MOST HECTIC SHEDULES CAN CREATE A FULL PUBLISH-READY MANUSCRIPTIN JUST A FEW MINUTES A DAY.
This Open Access edition of the European Society for Blood and Marrow Transplantation (EBMT) handbook addresses the latest developments and innovations in hematopoietic stem cell transplantation and cellular therapy. Consisting of 93 chapters, it has been written by 175 leading experts in the field.
Discussing all types of stem cell and bone marrow transplantation, including haplo-identical stem cell and cord blood transplantation, it also covers the indications for transplantation, the management of early and late complications as well as the new and rapidly evolving field of cellular therapies.
This book provides an unparalleled description of current practices to enhance readers’ knowledge and practice skills.
This study covers the world outlook for human embryonic stem cell (hESC) research across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E., for human embryonic stem cell (hESC) research. It also shows how the P.I.E. is divided across the world’s regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.